AHRQ set to disburse $300M for comparative effectiveness projects
Of the $300 million appropriated by ARRA to comparative effectiveness research, $148 million in grants will be provided for evidence generation. This includes $100 million for the Clinical and Health Outcomes Initiative in Comparative Effectiveness and $48 million for the establishment of national patient registries that can be used for researching longitudinal effects of different interventions and collecting data for under-represented populations.
Another $29.5 million will fund innovative translation and dissemination grants for comparative effectiveness research, and $20 million will be spent to support training and career development.
The AHRQ said $9.5 million will be issued in contracts to establish an infrastructure to identify new or emerging issues for comparative effectiveness review investments and $10 million will be used to establish a citizen’s forum to encourage public involvement in AHRQ’s Effective Health Care program.
In addition, funding will be used to support existing contracts for evidence synthesis ($50 million), evidence generation ($24 million), translation and dissemination ($5 million) and salary and benefits for ARRA-related full-time positions ($3 million).